274 related articles for article (PubMed ID: 21292681)
21. [Cardiac natriuretic peptides in heart failure].
Cvorisćec D; Cepelak I
Lijec Vjesn; 2006; 128(9-10):279-85. PubMed ID: 17128666
[TBL] [Abstract][Full Text] [Related]
22. B type natriuretic peptide--a diagnostic breakthrough in peri-operative cardiac risk assessment?
Rodseth RN
Anaesthesia; 2009 Feb; 64(2):165-78. PubMed ID: 19143695
[TBL] [Abstract][Full Text] [Related]
23. FPIN's clinical inquiries: brain natriuretic peptide for ruling out heart failure.
Cullan A; Grover M; Hitchcock K
Am Fam Physician; 2011 Jun; 83(11):1333-4. PubMed ID: 21661716
[No Abstract] [Full Text] [Related]
24. [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels].
Lindstedt G; Dahlström U; Fernlund P; Schaufelberger M; Stridsberg M
Lakartidningen; 2001 Oct; 98(41):4444-8, 4450-2. PubMed ID: 11699251
[TBL] [Abstract][Full Text] [Related]
25. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C
J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053
[TBL] [Abstract][Full Text] [Related]
26. [Variation in the plasma concentration of B-type natriuretic peptide in emergent paroxysmal atrial fibrillation, in acute pulmonary embolism, in acute coronary syndrome and in dilated cardiomyopathy].
Coppola A; De Paola G; Suppa M; Maggi B; Giancaspro G; Colzi M; Arcieri A; Scarpellini G; Manetti E; Lacenere L; Gerratana G; Santulli M; Aguglia F
Ann Ital Med Int; 2005; 20(3):167-86. PubMed ID: 16250184
[TBL] [Abstract][Full Text] [Related]
27. [Natriuretic peptides and their use in clinical practice according to the guidelines of the European Society of Cardiology].
Stryjewski PJ; Nessler B; Paweł M; Badacz L; Nowak J; Nessler J
Przegl Lek; 2014; 71(1):33-5. PubMed ID: 24712266
[TBL] [Abstract][Full Text] [Related]
28. [Patient with acute dyspnea. Heart disease or lung disease? Natriuretic peptide type B clarifies diagnosis].
MMW Fortschr Med; 2002 Dec; 144(51-52):12. PubMed ID: 12596676
[No Abstract] [Full Text] [Related]
29. Serum biomarkers for heart failure.
Jarolim P
Cardiovasc Pathol; 2006; 15(3):144-9. PubMed ID: 16697927
[TBL] [Abstract][Full Text] [Related]
30. Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure.
Lewandrowski K
Clin Lab Med; 2009 Sep; 29(3):561-71. PubMed ID: 19840688
[TBL] [Abstract][Full Text] [Related]
31. Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease.
Mueller C; Laule-Kilian K; Frana B; Rodriguez D; Scholer A; Schindler C; Perruchoud AP
Am Heart J; 2006 Feb; 151(2):471-7. PubMed ID: 16442916
[TBL] [Abstract][Full Text] [Related]
32. [Redefinition of myocardial infarction--relevance of biomarkers].
Weber M; Hamm C
Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
[TBL] [Abstract][Full Text] [Related]
33. The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure.
Vaz Pérez A; Doehner W; von Haehling S; Schmidt H; Zimmermann AV; Volk HD; Anker SD; Rauchhaus M
Int J Cardiol; 2010 May; 141(1):39-43. PubMed ID: 19155075
[TBL] [Abstract][Full Text] [Related]
34. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
Lindstedt G
Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
[No Abstract] [Full Text] [Related]
35. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients.
Hammerer-Lercher A; Puschendorf B; Mair J
Clin Lab; 2001; 47(5-6):265-77. PubMed ID: 11405605
[TBL] [Abstract][Full Text] [Related]
36. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.
Mueller C; Scholer A; Laule-Kilian K; Martina B; Schindler C; Buser P; Pfisterer M; Perruchoud AP
N Engl J Med; 2004 Feb; 350(7):647-54. PubMed ID: 14960741
[TBL] [Abstract][Full Text] [Related]
37. Updating the role of natriuretic peptide levels in cardiovascular disease.
Gopal DJ; Iqbal MN; Maisel A
Postgrad Med; 2011 Nov; 123(6):102-13. PubMed ID: 22104459
[TBL] [Abstract][Full Text] [Related]
38. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
Stoupakis G; Klapholz M
Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
[TBL] [Abstract][Full Text] [Related]
39. Brain natriuretic peptide and acute coronary syndrome.
Mazzone M; Forte P; Portale G; Mancini F; Ursella S; La Sala M; Testa A; Covino M; Pignataro G; Gentiloni Silveri N
Minerva Med; 2005 Feb; 96(1):11-8. PubMed ID: 15827538
[TBL] [Abstract][Full Text] [Related]
40. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide.
Hülsmann M; Berger R; Mörtl D; Gore O; Meyer B; Pacher R
Eur J Heart Fail; 2005 Jun; 7(4):552-6. PubMed ID: 15921794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
